Invivyd Inc.
$ 0.59
-2.72%
28 Jul - close price
- Market Cap 179,681,000 USD
- Current Price $ 0.59
- High / Low $ 0.62 / 0.58
- Stock P/E N/A
- Book Value 0.72
- EPS -0.29
- Next Earning Report 2026-08-13
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.30 %
- ROE -0.60 %
- 52 Week High 3.07
- 52 Week Low 0.48
About
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases in the United States. The company is headquartered in Waltham, Massachusetts.
Analyst Target Price
$10.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-14 | 2026-03-05 | 2025-11-06 | 2025-08-14 | 2025-05-15 | 2025-03-20 | 2024-11-14 | 2024-08-14 | 2024-05-09 | 2024-03-28 | 2023-11-09 | 2023-08-10 |
| Reported EPS | -0.13 | -0.0393 | -0.06 | -0.12 | -0.14 | -0.15 | -0.51 | -0.4 | -0.38 | -0.67 | -0.36 | -0.46 |
| Estimated EPS | -0.08 | -0.0864 | -0.09 | 0.01 | -0.04 | -0.1 | -0.35 | -0.39 | -0.39 | -0.42 | -0.5 | -0.45 |
| Surprise | -0.05 | 0.0471 | 0.03 | -0.13 | -0.1 | -0.05 | -0.16 | -0.01 | 0.01 | -0.25 | 0.14 | -0.01 |
| Surprise Percentage | -62.5% | 54.5139% | 33.3333% | -1300% | -250% | -50% | -45.7143% | -2.5641% | 2.5641% | -59.5238% | 28% | -2.2222% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-13 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | -0.15 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: IVVD
2026-07-27 15:40:17
This article provides a detailed historical cash flow statement for Invivyd Inc (IVVD), including operating, investing, and financing cash flows presented quarterly and annually. It details changes in various cash flow components and offers FAQs defining key financial terms like operating cash flow, investing cash flow, financing cash flow, and free cash flow, along with Invivyd Inc's specific figures for recent periods. The financial data highlights the company's past cash generation and usage across its business activities.
2026-07-26 23:48:27
This article provides an earnings forecast for Invivyd Inc (IVVD), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights that the company ranks 13th in the Pharmaceuticals industry with a 'Buy' trend from analysts, and includes expected revenue and EPS for upcoming quarters. Financial forecasting for EPS and revenue are also discussed.
2026-07-26 12:10:43
This article details the shareholder structure of Invivyd Inc (IVVD), listing its major shareholders and their proportions, as well as an analysis of shareholder types such as hedge funds, investment advisors, and venture capital firms. It also provides a historical overview of institutional shareholding, showing changes in the number of institutions and shares held over several quarters. Key individual shareholder activity with their respective changes in holdings is also presented.
2026-07-26 11:40:17
Invivyd, Inc. is a biopharmaceutical company focused on developing antibody-based therapies for viral threats like SARS-CoV-2, utilizing its proprietary INVYMAB platform. Their primary product, PEMGARDA, is authorized for pre-exposure prophylaxis of COVID-19, and they have other candidates like VYD2311 in development. The company profile includes financial data, key executives, and shareholding information, detailing institutional ownership.
2026-07-26 09:10:20
This article provides a detailed quarterly and annual income statement for Invivyd Inc. (IVVD), including revenue, operating expenses, profit, and earnings per share. It also includes an FAQ section explaining how to interpret the income statement and key financial metrics. The data shows recent revenue and net income figures for the company.
2026-07-26 05:10:20
This article provides an overview of Invivyd Inc.'s (IVVD) historical dividend payouts and stock splits. It indicates that the company has distributed a total of $0.00 USD in dividends over the past five years, with no specific dividend data available. The content also briefly states the company's current stock price, market cap, and links to other financial and corporate information.
